Page last updated: 2024-08-26

sr141716 and Atrophy, Muscle

sr141716 has been researched along with Atrophy, Muscle in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Combe, K; Lanchais, K; Le Bacquer, O; Van Den Berghe, L; Walrand, S	1

Other Studies

1 other study(ies) available for sr141716 and Atrophy, Muscle

Article	Year
Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism. Journal of cellular physiology, 2021, Volume: 236, Issue:4 Topics: Animals; Calcium; Cannabinoid Receptor Antagonists; Dexamethasone; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Protein Biosynthesis; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases	2021

Article

Year

Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.

Journal of cellular physiology, 2021, Volume: 236, Issue:4

Topics: Animals; Calcium; Cannabinoid Receptor Antagonists; Dexamethasone; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Protein Biosynthesis; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases

2021